NACDS continues to advance “NACDS 2023” – a member-driven initiative that is innovating the Association’s approach to serving retailer and supplier members as they bring a “total store, total person” vision to health and wellness – in the pharmacy and beyond.
The 2023 NACDS Regional Chain Conference continued today with more presentations from top speakers on the most timely issues affecting the industry and the patients and consumers it serves.
A White House ceremony on Tuesday marked the end of the “X-waiver” requirement.
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
Inclusion of the INFORM Consumers Act marks a major bipartisan step toward curbing the organized retail crime networks jeopardizing Americans’ safety.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
From August 27-29, small, mid-size and large companies converged at the Boston Convention & Exhibition Center to collaborate, connect and foster strategic business partnerships.
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
With the 2022 NACDS Total Store Expo set to launch, the Boston Business Journal this morning published an op-ed authored by NACDS President & CEO Steven C. Anderson.
